Abstract

Use of a Closed-system Drug Transfer Device (PhaSeal) and Impact on Preparation Time

Author(s): Sanchez-Rubio Ferrandez J, Lozano M C, Iglesias I, Sanchez-Rubio Ferrandez L, Rodriguez Vargas B, Moreno Diaz R

Issue: Sep/Oct 2012 - Volume 16, Number 5

Page(s): 431-433

Download in electronic PDF format for $75
  • Use of a Closed-system Drug Transfer Device (PhaSeal) and Impact on Preparation Time Page 1
  • Use of a Closed-system Drug Transfer Device (PhaSeal) and Impact on Preparation Time Page 2
  • Use of a Closed-system Drug Transfer Device (PhaSeal) and Impact on Preparation Time Page 3

Abstract

PhaSeal is a closed-system drug transfer device which has demonstrated to protect against occupational exposure to antineoplastic agents. Our aim was to assess the impact of the incorporation of PhaSeal on the processing time of chemotherapy. The study was a prospective simulation study which compared the processing times with the traditional open-system technique and using the closed-transfer system. Four experienced pharmacy technicians prepared six batches with each method simulating simple chemotherapy admixture operations. We compared the mean times obtained by student's t test and evaluated the “learning effect” between days by ANOVA. The average percentage of time saving with PhaSeal was 31.7% (time per batch [mean±SD] 6.44+0.73 vs. 9.44+0.98 minutes). Mean difference was statistically significant (3.0 min IC95% 2.50-3.50; p>0.0001). No significant learning curve effect was detected. The BD Medical/Carmel Pharma PhaSeal system, in addition to its protective properties, is able to save time in the elaboration process which leads to organization advantages for hospital pharmacy services.

Related Keywords

  • closed-system drug transfer
  • chemotherapy agents
  • occupational exposure
  • preparation time

Related Categories

  • CANCER AND AIDS
  • PEER-REVIEWED
  • TECHNOLOGY
  • PROFESSIONAL ISSUES

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy		 Title/Author
(Click for Abstract / Details / Purchase)
Sep/Oct 2012
Pg. 431-433
Use of a Closed-system Drug Transfer Device (PhaSeal) and Impact on Preparation Time
Author(s): Sanchez-Rubio Ferrandez J, Lozano M C, Iglesias I, Sanchez-Rubio Ferrandez L, Rodriguez Vargas B, Moreno Diaz R
Mar/Apr 2016
Pg. 148-154
Safe Cytotoxic Drug Preparation Using a Closed-system Transfer Device: Technical and Practical Evaluation of a New Device (Vialshield/Texium) Comparatively to a Reference One (Phaseal)
Author(s): Garrigue Philippe, Montana Marc, Ventre Christophe, Savry Amadine, Gauthier-Villano Laurence, Pisano Pascale, Pourroy Bertrand
Jan/Feb 2022
Pg. 72-79
Evaluation of Closed-system Transfer Devices in Reducing Potential Risk for Surface Contamination Following Simulated Hazardous-drug Preparation and Compounding (Reprint)
Author(s): Soefje Scott, Rickabaugh Keith, Rajkumar Rahul, Wall Kathryn P
Nov/Dec 2021
Pg. 515-522
Evaluation of Closed-system Transfer Devices in Reducing Potential Risk for Surface Contamination Following Simulated Hazardous-drug Preparation and Compounding
Author(s): Soefje Scott, Rickabaugh Keith, Rajkumar Rahul, Wall Kathryn P
Sep/Oct 2022
Pg. 358-362
Hazardous Drug Enteral Device: A Closed System Device for Crushing and Dispersing Hazardous Drug Tablets for Enteral Administration
Author(s): Lopez C Vidal, Rios GL Quito
Jul/Aug 2001
Pg. 310-312
Wetting and/or Solubilizing Agents, Featured Excipient:
Author(s): Allen Loyd V Jr
Mar/Apr 2023
Pg. 154-159
Extending Practical (In Use) Shelf Life of Oncology Drug Vials Using Spikes
Author(s): de Wilde Sofieke, Crul Mirjam, Breukels Oscar
Mar/Apr 2023
Pg. 169-174
Comparison of Three Reconstitution Devices: A Simulated Time and Use Study
Author(s): Penoyer Daleen, Giuliano Karen, Middleton Aurea
Mar/Apr 2004
Pg. 126-129
Basics of Compounding for the Treatment of Warts
Author(s): Allen Loyd V Jr
Mar/Apr 2014
Pg. 94-99
A Needle-free Reconstitution and Transfer System for Compounded Sterile Intravenous Drug Solutions: In Compliance with United States Pharmacopeia Chapter <797> Standards
Author(s): Marks Zach
Jan/Feb 2015
Pg. 30-37
Agar Transfer Devices for Environmental Sampling in the Compounding Pharmacy: Science and Compliance
Author(s): Grilli Anthony, Sutton Scott
Nov/Dec 2012
Pg. 446-450
The Drug Enforcement Agency's Position on "Constructive Transfer" Under the Controlled Substances Act
Author(s): Pore R David
Nov/Dec 2019
Pg. 454-461
How to Qualify Container Closure Systems for Intended Use, Part 1
Author(s): Kim Amy A, Gehrmann Matthew R, McCaw James, McAndrew T Page
Jul/Aug 2023
Pg. 340-346
Formulation and In Vitro Evaluation of a Ramipril Entrapped in a Microsponge-based Drug-delivery System
Author(s): Taghi Hassanien Sagban, Abdulbaqi Mustafa R, Samein Laith Hamza, Rahmani Maha H Philip
Nov/Dec 2012
Pg. 456-460
Drug Shortage Compounding: The Only Safe Medication Source in a Time of Crisis
Author(s): Lyon Joanna
Jul/Aug 2011
Pg. 308-315
Transdermals: The Skin as Part of a Drug Delivery System
Author(s): Allen Loyd V Jr
Mar/Apr 2018
Pg. 108-121
Personalized Medicine and Customized Drug Delivery Systems: The New Trend of Drug Delivery and Disease Management
Author(s): Soni Abhishek, Gowthamarajan Kuppusamy, Radhakrishnan Arun
Jan/Feb 2017
Pg. 47-56
Basics of Sterile Compounding: Biopharmaceutics of Injectable Dosage Forms
Author(s): Akers Michael J
Jul/Aug 2017
Pg. 301-308
Basics of Sterile Compounding: Excipients Used in Injections
Author(s): Akers Michael J
Mar/Apr 2021
Pg. 131-139
Intravenous Admixture Preparation Considerations, Part 9-A: Error Prevention in Intravenous Admixture Preparation
Author(s): Allen Loyd V Jr